Exploring Spatial-Temporal Changes in 18F-Sodium Fluoride PET/CT and Circulating Tumor Cells in Metastatic Castration-Resistant Prostate Cancer Treated With Enzalutamide.

Christos Kyriakopoulos,Elisabeth I. Heath,Anna C. Ferrari,Jamie M. Sperger,Anupama Singh,Scott B. Perlman,Alison Roth,Timothy Perk,Katharina Modelska,Anthony R. Porcari,William T. Duggan,Joshua M. Lang,Robert Jeraj,Glenn Liu

Exploring Spatial-Temporal Changes in 18F-Sodium Fluoride PET/CT and Circulating Tumor Cells in Metastatic Castration-Resistant Prostate Cancer Treated With Enzalutamide.

2020

Christos Kyriakopoulos
Elisabeth I. Heath
Anna C. Ferrari
Jamie M. Sperger
Anupama Singh
Scott B. Perlman
Alison Roth
Timothy Perk
Katharina Modelska
Anthony R. Porcari
William T. Duggan
Joshua M. Lang
Robert Jeraj
Glenn Liu

PURPOSEIntrapatient treatment response heterogeneity is under-recognized. Quantitative total bone imaging (QTBI) using 18F-NaF positron emission tomography/computed tomography (PET/CT) scans is a t...

Keywords:

castration resistant
Positron emission tomography
Nuclear medicine
PET-CT
Enzalutamide
Bone imaging
Sodium fluoride
Circulating tumor cell
Prostate cancer
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations